Latest filing published 08 Jan 2019 for Intra-Cellular Therapies, Inc., €68k.
Filing timeline
BuySaleInsider track record
Robert E. Davis: trading record in brief
This profile gathers the share dealings of Robert E. Davis in Intra-Cellular Therapies, Inc. Over a trading history stretching from 4 December 2016 to 4 January 2019, the count stands at 13 filings.
On the market, this insider has only sold: 6 sales, €177k in total. Other entries cover 1 share grant and 6 option exercises. In 2019 alone, the filings show no purchases and 3 sales.
Most recently, on 8 January 2019, the filings show an open-market sale worth €68k in Intra-Cellular Therapies, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert E. Davis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,862 shares@ US$11.3340.6% of flowCommon StockSEC:0001209191-19-002955:0
- 2,702 shares@ US$11.8016.6% of flowCommon StockSEC:0001209191-19-002955:1
- 9,322 shares0Common StockSEC:0001209191-19-001584:0
- 2,649 sharesCommon StockSEC:0001209191-19-001584:2
- 16,160 sharesCommon StockSEC:0001209191-19-001584:3
- 4,834 shares@ US$11.1127.8% of flowCommon StockSEC:0001209191-19-001584:1
- 899 shares@ US$13.536.4% of flowCommon StockSEC:0001209191-18-061525:1
- 1,758 sharesCommon StockSEC:0001209191-18-061525:0
- 2,648 sharesCommon StockSEC:0001209191-18-002591:0
- 1,115 shares@ US$15.608.2% of flowCommon StockSEC:0001209191-18-002591:1
- 1,757 sharesCommon StockSEC:0001209191-17-064255:0
- 650 shares@ US$15.004.7% of flowCommon StockSEC:0001209191-17-064255:1
- 1,757 sharesCommon StockSEC:0001209191-17-002276:0
13 of 13 declarations
